Aridis Pharmaceuticals, Inc. ARDS
Set alert
0.00 USD 0.00 0.00%
At close · Nov 2
0.00145 Day range 0.00145
0.0001 52-week range 0.05
- YTD
- -86.67%
- 1 year
- -89.19%
- Open
- 0.00145
- Prev close
- 0.0002
- Mkt cap
- 8.91K
- Vol
- 10
- Avg vol
- 3.33K
- EPS
- -0.32
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.00145
- High
- 0.00145
- Forward P/E
- 1.35
- Beta
- 0.78
- Short ratio
- 0.22
- Inst. own
- 11.60%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 23, 2024
- 50-d avg
- 0.2338
- 200-d avg
- 0.63715
- 1y target
- 10.00
6M chart
Signals (30)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 23, 2026 | 1 week ago |
| MACD: Buy Signal | Jul 23, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 26, 2026 | 4 months ago |
| SMA: Bearish | Jun 25, 2026 | 4 months ago |
| SMA: Bearish | Jun 25, 2026 | 4 months ago |
| SMA: Bullish | Jun 16, 2026 | 4 months ago |
| SMA: Bullish | Jun 16, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 16, 2026 | 4 months ago |
| SMA: Bearish | May 28, 2026 | 5 months ago |
| SMA: Bearish | May 28, 2026 | 5 months ago |
| MACD: Sell Signal | May 28, 2026 | 5 months ago |
| MACD: Buy Signal | May 26, 2026 | 5 months ago |
| SMA: Bullish | May 22, 2026 | 5 months ago |
| SMA: Bullish | May 22, 2026 | 5 months ago |
| MACD: Sell Signal | May 20, 2026 | 5 months ago |
| SMA: Bearish | May 19, 2026 | 5 months ago |
| SMA: Bearish | May 19, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| SMA: Bearish | May 15, 2026 | 5 months ago |
Newest 20 of 30.
Analyst view
Consensus: buy
Buy
Price target (mean) 10.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy0
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -0.44 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.45 | 0.0% | 0 | 0.0% | 0 |
| Current year | -0.54 | -1.52 – 0.44 | -1.62 | +66.7% | 37.50M | +1113.2% | 2 |
| Next year | 0.26 | 0.26 – 0.26 | -0.54 | +148.1% | 41.41M | +10.4% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 26, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 16, 2022 | Maxim Group | Downgrade | Buy | Hold |
| Jul 20, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| May 15, 2020 | H.C. Wainwright | Reiterated | — | Buy |
| Feb 19, 2020 | Roth Capital | Initiated | — | Buy |
| Dec 30, 2019 | H.C. Wainwright | Initiated | — | Buy |
| Sep 10, 2018 | Northcoast Research | Initiated | — | Outperform |
| Sep 10, 2018 | Laidlaw & Co. | Initiated | — | Buy |
| Sep 10, 2018 | Cantor Fitzgerald | Initiated | — | Overweight |